The timeline shows Eli Lilly's capital expenditures from 2013 to 2024. In 2024, the company's capital expenditures amounted to 5.06 billion U.S. dollars. Eli Lilly is one of the global leading pharmaceutical companies and one of the world's largest manufacturers of diabetes medications.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Eli Lilly and Company, & U.S. Securities and Exchange Commission. (February 19, 2025). Capital expenditure from 2013 to 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 20, 2026, from /statistics/974433/eli-lilly-capital-expenditures/
Eli Lilly and Company, und U.S. Securities and Exchange Commission. "Capital expenditure from 2013 to 2024 (in million U.S. dollars)." Chart. February 19, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 20, 2026. /statistics/974433/eli-lilly-capital-expenditures/
Eli Lilly and Company, U.S. Securities and Exchange Commission. (2025). Capital expenditure from 2013 to 2024 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 20, 2026. /statistics/974433/eli-lilly-capital-expenditures/
Eli Lilly and Company, and U.S. Securities and Exchange Commission. "Capital Expenditure from 2013 to 2024 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 19 Feb 2025, /statistics/974433/eli-lilly-capital-expenditures/
Eli Lilly and Company & U.S. Securities and Exchange Commission, Capital expenditure from 2013 to 2024 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/974433/eli-lilly-capital-expenditures/ (last visited July 20, 2026)
Capital expenditure from 2013 to 2024 (in million U.S. dollars) [Graph], Eli Lilly and Company, & U.S. Securities and Exchange Commission, February 19, 2025. [Online]. Available: /statistics/974433/eli-lilly-capital-expenditures/
